# Oral Bedtime Melatonin in Critically Ill Patients

Study · id `cardio:ct-nct06156059` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06156059](<https://clinicaltrials.gov/study/NCT06156059>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06156059

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

## Technical summary

Registry record NCT06156059. Randomized; quadruple masking; primary purpose treatment. Start 2025-02-01 (anticipated); primary completion 2026-02-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT06156059, source copy `cardio:ctgov-nct06156059-2024-03-01`, retrieved 2026-10-26)
- Planned start: 2025-02-01 (anticipated) (ClinicalTrials.gov record NCT06156059, source copy `cardio:ctgov-nct06156059-2024-03-01`, retrieved 2026-10-26)
- Primary completion: 2026-02-01 (anticipated) (ClinicalTrials.gov record NCT06156059, source copy `cardio:ctgov-nct06156059-2024-03-01`, retrieved 2026-10-26)
- Completion: 2026-04-01 (anticipated) (ClinicalTrials.gov record NCT06156059, source copy `cardio:ctgov-nct06156059-2024-03-01`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06156059-2024-03-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Oral Bedtime Melatonin in Critically Ill Patients
- Acronym: Mel-ICU
- Condition: Septic Shock
- Condition: Stroke Hemorrhagic
- Condition: Strokes Thrombotic
- Condition: Cardiac Arrest
- Intervention (Drug): Oral Bedtime Melatonin
- Intervention (Drug): Placebo suspension or capsule
- Lead sponsor: Hospital San Carlos, Madrid
- Lead sponsor class: OTHER
- Collaborator: Universidad Complutense de Madrid
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Hospital San Carlos, Madrid (`cardio:org-hospital-san-carlos-madrid`)

## Provenance

Content hash: 28a8ade96e13a4a495e45c425779e4b46977a3c4e2953f6aa374511badb982f7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
